rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2002-7-30
|
pubmed:abstractText |
We tried to improve the evaluation of E-cadherin immunostaining in paraffin sections, to distinguish the less aggressive variants of ductal infiltrating breast cancer from other variants.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0309-0167
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
127-33
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12147090-Adult,
pubmed-meshheading:12147090-Aged,
pubmed-meshheading:12147090-Aged, 80 and over,
pubmed-meshheading:12147090-Breast Neoplasms,
pubmed-meshheading:12147090-Cadherins,
pubmed-meshheading:12147090-Carcinoma, Ductal, Breast,
pubmed-meshheading:12147090-Female,
pubmed-meshheading:12147090-Humans,
pubmed-meshheading:12147090-Immunohistochemistry,
pubmed-meshheading:12147090-Lymphatic Metastasis,
pubmed-meshheading:12147090-Middle Aged,
pubmed-meshheading:12147090-Mitotic Index,
pubmed-meshheading:12147090-Postmenopause,
pubmed-meshheading:12147090-Premenopause,
pubmed-meshheading:12147090-Prognosis,
pubmed-meshheading:12147090-Receptors, Estrogen
|
pubmed:year |
2002
|
pubmed:articleTitle |
Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance.
|
pubmed:affiliation |
Department of Pathology, University of Turku, Finland.
|
pubmed:publicationType |
Journal Article
|